Literature DB >> 7655392

Immune-mediated myelopathy after allogeneic marrow transplantation.

H Openshaw1, N E Slatkin, P M Parker, S J Forman.   

Abstract

We describe two patients who developed myelopathy 15 and 27 months after allogeneic marrow transplantation. Exacerbations of the myelopathy occurred, with the development of optic neuropathy in one patient when corticosteroid therapy was tapered. The other patient had two exacerbations, 28 months and 40 months after transplantation, both of which resolved with plasma-pheresis. These case reports suggest that immune-mediated disease after transplantation can affect the central nervous system.

Entities:  

Mesh：

Year:  1995        PMID： 7655392

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  9 in total

1.  Immune-mediated myelopathy following allogeneic stem cell transplantation.

Authors:  Miwa Sakai; Kazuteru Ohashi; Keiko Ohta; Takuya Yamashita; Hideki Akiyama; Shuji Kisida; Noriko Kamata; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

2.  Bilateral Inflammatory Optic Neuropathy Related to Graft versus Host Disease Following Allogeneic Bone Marrow Transplantation for Hodgkin Disease.

Authors:  I Moesen; D P Kidd
Journal:  Neuroophthalmology       Date:  2014-07-22

3.  A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.

Authors:  Gi-June Min; Silvia Park; Sung-Soo Park; Jae-Ho Yoon; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Seok Lee; Hee-Je Kim; Chang-Ki Min; Seok-Goo Cho; Dong-Wook Kim; Jong-Wook Lee; Yoo-Jin Kim
Journal:  Int J Hematol       Date:  2019-07-15       Impact factor: 2.490

4.  Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.

Authors:  Anna Maria Delios; Marc Rosenblum; Ann A Jakubowski; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2012-08-23       Impact factor: 4.130

5.  Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation.

Authors:  Martin W Hümmert; Michael Stadler; Florian Wegner; Thomas Skripuletz; Lothar Hambach; Stefan Gingele; Martin Bredt; Mike P Wattjes; Gudrun Göhring; Letizia Venturini; Nora Möhn; Martin Stangel; Corinna Trebst; Arnold Ganser
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

6.  Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia.

Authors:  Fredrick Hogan; Melhem Solh
Journal:  Case Rep Hematol       Date:  2014-09-14

7.  A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.

Authors:  Joyutpal Das; Atta Gill; Christine Lo; Natalie Chan-Lam; Siân Price; Stephen B Wharton; Helen Jessop; Basil Sharrack; John A Snowden
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

8.  Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells.

Authors:  Behnam Sadeghi; Bo Ersmark; Gianluca Moretti; Jonas Mattsson; Olle Ringdén
Journal:  Int J Hematol       Date:  2019-12-18       Impact factor: 2.490

Review 9.  Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.